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Purpose: To formulate mucoadhesive chlorhexidine tablets and evaluate their drug release 
characteristics and mechanism. 
Methods: Chlorhexidine buccal adhesive tablets were prepared by direct compression using a blend of 
hydroxypropyl methylcellulose (HPMC) and chitosan as the bioadhesive polymers. Their dissolution 
properties were assessed according to USP 24 (paddle method). In order to determine the mode of drug 
release from the tablets, the release data were subjected to various release kinetic models. The 
bioadhesive strength of the tablets was also evaluated. 
Results: The results showed that as the proportion of HPMC in the blend increased, drug release rate 
decreased, with the lowest release rate observed when HPMC alone was used as the bioadhesive 
polymer (p < 0.001). Both the type and ratio of the polymers used influenced release kinetics. Also, 
bioadhesion force increased with increasing proportion of HPMC in the tablets, with the highest 
adhesion force shown when HPMC was the only polymer used, and lowest when chitosan was used 
alone (p < 0.01).   
Conclusion: The chlorhexidine formulations developed showed promise as a bioadhesive delivery 
system for the drug. 
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INTRODUCTION 
 
A major difficulty in the effort to eradicate 
infections of the oral cavity is the dilution and 
rapid elimination of topically applied drugs 
due to the flushing action of saliva. The 
delivery system in which the drug is 
incorporated is, therefore, an important 
consideration and such a system should be 
formulated to prolong drug retention in the 
oral cavity. Efficient local delivery of actives 
such as dental bleaches and antimicrobials to 
the oral cavity is compromised by a number 
of factors that dramatically reduce residence 
time, most notably the shear forces 
associated with speaking, swallowing and 
mastication, as well as dilution and washout 
caused by continuous saliva production [1].  
 
Typical polymers that have been used as 
mucoadhesive drug carriers are poly (acrylic 
acid), poly(methacrylate acid), cellulose 
derivatives, poly(ethylene oxide), lectin and 
chitosan [2]. Many attempts have been 
undertaken to improve the mucoadhesive 
properties of polymers by preparing 
copolymers, polymer conjugates or 
interpolymer complexes. 
 
Buccal patches are generally based on 
bioadhesive polymers which, once hydrated, 
adhere to the buccal mucosa and withstand 
salivation, tongue movements and 
swallowing for a significant period of time. 
Successful buccal delivery requires at least 
three of the following: (a) a bioadhesive to 
retain the drug in the oral cavity and 
maximize the intimacy of contact with the 
mucosa; (b) a vehicle that releases the drugs 
at an appropriate rate under the conditions 
prevailing in the mouth; and (c) strategies for 
overcoming the low permeability of the oral 
mucosa. The three steps of formation of 
bioadhesive bonds are: (a) wetting and 
swelling of polymer; (b) entanglement of 
polymer and mucin chains and (c) formation 
of week chemical bonds between entangled 
chains [3].  
 
Chlorhexidine is a bis-bis-guanide widely 
used to treat skin and mucosa infections 
efficiently against a wide range of microbial 
species. Senel et al designed a formulation 
containing chitosan for local delivery of 
chlorhexidine to the oral cavity. Release of 
chlorhexidine from the gels was maintained 
for 3 h [4]. Hita-Iglesias et al studied the 
effectiveness of chlorhexidine gel versus 
chlorhexidine rinse in reducing alveolar 
osteitis in mandibular third molar surgery. 
They showed that the topical application of 
bioadhesive chlorhexidine gel to the surgical 
wound during the postoperative week may 
decrease the incidence of alveolar osteitis 
after extraction of the mandibular third molar 
[5]. 
 
In this study, tablets containing chlorhexidine 
were formulated and evaluated for their 







Chlorhexidine was purchased from Shaher 
Daru, Tehran, Iran, while polycarbophil and 
Carbopol 914P were obtained from 
BF.Goodrich (USA). Hydroxypropyl 
methylcellulose (HPMC K15M) from Colorcon 
(UK) and chitosan (Fluka, Switzerland) were 
also used. 
 
Preparation of bioadhesive tablets 
 
Flat-faced 9 mm chlorhexidine buccal 
adhesive tablets were prepared by direct 
compression in a hydraulic press (Spectalab, 
India) at a constant compression pressure 
from mixtures of the ingredients. The 
composition of the tablet formulations is given 
in Table 1. 
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Table 1: Composition of 55.5 mg chlorhexidine 








F1 55.50 --- 
F2 --- 55.50 
F3 37.00 18.50 
F4 18.50 37.00 
F5 27.25 27.25 
 
In vitro dissolution 
 
The dissolution tests were performed using 
the paddle method of USP 24. with the aid of 
a dissolution apparatus (Erweka, DT 800 
Germany) rotating at 100 rpm [6]. The 
dissolution medium was 900 ml phosphate 
buffer (pH 6.8) and the temperature was set 
at 37 
0
C. Samples of the solution were 
withdrawn at definite time intervals. The 
dissolution media was then replaced by fresh 
dissolution fluid to maintain a constant 
volume. The solution was passed through a 
filter and then the concentration of 
chlorhexidine in solution was measured with 
an ultraviolet spectrophotometer (Spectonic 
Genesys 2, USA) at a wavelength of 257 nm. 
The test was carried out in triplicate and the 
results expressed as mean ± standard 
deviaition (SD). 
 
Analysis of drug release kinetics 
 
In order to investigate the mode of drug 
release from the tablets, the release data 
were subjected to the following release 
models: zero order, first order, square root of 
time and Korsemeyer-Peppas, as shown in 
Eqs 1 – 4, respectively. 
 
Q = kot  ..................................................   (1) 
ln (100 – Q) = ln Q0 – k1t .......................   (2) 
Q = kHt
1/2
……………………….…..……..   (3) 
Q = kpt
n 
………………………….….……..  (4) 
 
where Q is drug released at time, t, while k0, 
k1 and kH are coefficients of the respective 
equations; kp is a constant incorporating 
structure and geometric characteristics of the 
release device; and n is the release exponent 
indicative of the mechanism of release. When 
n approximates to 0.5, a Fickian/diffusion-
controlled release is implied; 0.5 < n < 1.0 
indicates non-Fickian transport; and n = 1 is 
zero order (case II transport). When the value 
of n approaches 1.0, it can be said that 
release approximates zero order [7]. 
 
Determination of bioadhesive strength 
 
To evaluate bioadhesive strength, a tensile 
tester apparatus, similar to an Instron model 
4301 tensile tester, was fabricated. The male 
albino rat (200 - 250 g) was killed under ether 
anaesthesia and the hairless skin was 
isolated from the dorsal section of the 
abdomen. The skin (mucosa side) was fixed 
across the opening (area: 2 cm
2
) of a 
diffusion cell filled with phosphate buffer (pH 
6.8). The test was carried out in triplicate as 
previously described [7] and the results 
expressed as mean ± standard deviation 
(SD). The animal studies were approved by 
the Research Ethics Committee of the 
Council of Mazandaran University of Medical 




A one-way ANOVA with Tukey's post hoc test 
was used to analyze the dissolution and 
bioadhesion data, with the aid of SPSS 
software, version 10. Confidence limit was 




Fig 1 shows the effect of HPMC/chitosan 
ratio on the release rate of chlorhexidine. The 
results show that as the concentration of 
HPMC increased, the release rate 
decreased. The lowest release rate was 
observed with formulation F1 containing 
containing HPMC but no chitosan while 
formulation F2 which contained only chitosan 
exhibited the highest release rate.  
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Figure 1: In vitro release of chlorhexidine from 
formulations F1 (▲, HPMC alone); F2 (■, chitosan 
alone) , F3 (○, HPMC:chitosan, 0.75:0.25); F4 (□, 
HPMC:chitosan, 0.25:0.75); and F5 (●, 
HPMC:chitosan, 0.5:0.5. Note: Error bars denote 
standard deviation.  
 
The results of the kinetic analysis of the data 
are shown in Table 2. Altering the type of 
polymer and polymer ratio influenced the 
release kinetics of chlorhexidine from the 
buccoadhesive tablets. Kinetic analysis of the 
release data showed that polymer ratio 
influenced drug release kinetics. 
Furthermore, high correlation coefficients 
were achieved with the various release 
models.  
 
The bioadhesive strengths of the 
mucoadhesive tablets are shown in Fig 2. 
The results show that bioadhesive strength 
increased with increase in the concentration 
of HPMC with the highest value exhibited by 
formulation F1 which contains only HPMC. 
On the other hand, the lowest adhesive 
strength was manifested by formulation F5 































Figure 2: Bioadhesive strength of chlorhexidine 
formulations. Note: F1 = HPMC alone; F2 
chitosan alone; F3 = HPMC: chitosan, 0.75:0.25; 





Due to its bioadhesive property, 
mucoadhesive tablets are expected to remain 
in the oral cavity and release its drug content 
for a long period of time, thus providing 
sustained therapeutic effect. 
 
HPMC is a semi-synthetic ether derivative of 
cellulose. It has been a dominant hydrophilic 
vehicle used in controlled release dosage 
forms because of its non-toxic nature, ease of 
compression, and capacity to accommodate 
high levels of drug loading [8]. One of its 
most important characteristics is high 
swellability which exerts a significant 
influence on the release kinetics of a 
incorporated drug in it. Upon contact with 
water or biological fluid, the fluid diffuses into 
the device, resulting in polymer chain 
relaxation leading to volume expansion. The 





























F1 0.0012 0.9863 -0.0024 0.9416 0.0332 0.9265 0.0425 0.54 0.8679 
F2 0.0028 0.9890 -0.0227 0.8686 0.0454 0.9595 0.0540 0.57 0.9245 
F3 0.0019 0.9991 -0.0066 0.8511 0.0501 0.9689 0.0406 0.59 0.9456 
F4 0.0021 0.9906 -0.0141 0.8222 0.4470 0.9443 0.3169 0.55 0.9684 
F5 0.0020 0.9957 -0.0073 0.9040 0.0448 0.9564 0.1977 0.59 0.9639 
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incorporated drug then diffuses out of the 
system [9]. Chitosan, a cationic natural 
biopolymer produced from deacetylation of 
chitin, has been widely used for drug carrying 
devices in controlled drug delivery systems 
[10]. The incorporation of a drug into chitosan 
matrix to form a monolithic device can 
expand the use of this biopolymer. 
Depending on the amount of chitosan, film 
thickness, and dissolution medium, the 
liberation of drug from the chitosan films 




Incorporation of HPMC decreased the 
release rate of drug because the polymer 
absorbs water and forms a gelatinous barrier 
layer at the surface of the tablet matrix, unlike 
chitosan which does not form a gel layer. 
Thus, increasing the level of HPMC in the 
tablet produced a stronger gel layer around 
the matrix resulting in decreased penetration 
of the solvent molecules in to the matrix and 
outward diffusion of drug molecules into the 
dissolution medium. Usually, water diffusivity 
depends on the total concentration of 
viscosity-inducing agents in a systems and 
this governs diffusion of water into matrix 
systems. Furthermore, erosion can play a 
role in drug release. Resistance of the gel 
layer to erosion is usually controlled by the 
viscosity grade of the HPMC used. Water 
soluble drugs are released primarily by 
diffusion of dissolved drug molecules across 
the gel layer whilst poorly water soluble drugs 
are released predominately by erosion 
mechanisms [12]. 
 
Kinetic analysis of the release data showed 
that varying HPMC/chitosan ratio affected the 
release kinetics of chlorhexidine from the 
buccoadhesive tablets and the high 
correlation coefficients were achieved with 
the various models. The release exponent, n, 
of the Korsemeyer-Peppas model, which was 
> 0.5 but less than 1, indicates a coupling of 
diffusion and erosion mechanisms, i.e., the 
so-called anomalous diffusion. The 
Korsemeyer-Peppas model is a 
generalization of the observation that 
superimposes two apparently independent 
mechanisms of drug transport, namely, 
Fickian diffusion and a case-II transport 
which describes drug release from a swollen 
polymer. When n takes the value 0.5 it 
indicates diffusion-controlled drug release 
while the value 1.0 indicates swelling-
controlled drug release. Values of n between 
0.5 and 1.0 can be regarded as an indicator 
for both phenomena, i.e., anomalous 
transport, as stated above [7].  
 
Drug release from swollen polymer matrix 
matrices is based on glassy-rubbery 
transition of the polymer which occurs as a 
result of water penetration into the matrix. 
Although interactions between water, polymer 
and drug are the primary factors in release 
control, several formulation variables also 
influence drug release rate to a greater or 
lesser degree. Thus, drug loading, drug 
polymer ratio, drug particle size, HPMC 
viscosity could also have modifiers 




In the buccal region, a tablet may be adhered 
either to the buccal tissue (cheek) or the 
gingival. For local drug delivery, the highly 
keratinized epidermis of the gingival will 
present a barrier to systemic absorption. 
Examples of oral cavity diseases for which 
buccal dosage forms have been designed 
include aphthous stomatitis, oral candidiasis, 
and periodontal disease [14]. 
 
Various classes of polymers have been 
investigated for their mucoadhesive 
properties, such as hydrogen-bonding 
functional groups, suitable wetting properties, 
swelling/water load properties, and sufficient 
flexibility for entanglement with tissue mucus 
network. The mucosal surface are covered 
with a mucus layer, in which mucins are the 
major component [15]. Mucins are highly 
glucosylated glycoproteins with a large 
peptide backbone and oligosaccharides as 
side chains. As a result, mucins are 
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negatively charged at physiological pH. 
Mechanisms of polymer attachment to 
mucosal surfaces are not yet fully 
understood. However, certain theories of 
bioadhesion have suggested that it might 
occur via physical entanglement (diffusion 
theory) and/or chemical interactions, such as 
electrostatic, hydrophobic, hydrogenbonding, 
and Van der waals interactions [16]. 
  
In general, mucoadhesion is considered to 
occur in three stages, namely, wetting, 
penetration and mechanical interlocking 
between polymer and mucus membrane [15]. 
It is understood that mucoadhesive polymers 
could interact with mucous glycoprotein by 
forming physical and chemical 
entanglements, followed by hydrogen bonds 
with sugar residues on oligosaccharide 
chains that result in the formation of a 
strengthened mucous gel network that allows 
the formulations to remain adhesive for an 
extended period of time [17]. 
 
As stated earlier, increase in the 
concentration of HPMC resulted in increased 
mucoadhesive strength. This is in agreement 
with the findings of Ikinci et al who also 
observed that bioadhesion force increased 
with increasing HPMC concentration in 
tablets [18]. HPMC is a long chained, 
nonionic polymer and so its mucoadhesion is 
attributable to the formation of physical 
(including hydrogen) bonds with the mucus 
components. It possesses a large number of 
hydroxyl groups that are responsible for 
adhesion. Formation of hydrogen bonds 
between the hydrophilic functional groups of 
mucoadhesive polymers and the mucus layer 
or the mucosal surface is a prerequisite for 
extensive and longer mucoadhesion [17]. The 
increased sites for bond formation may 
explain the increase in bioadhesion with 
increase in its concentration.  
 
Unlike most known bioadhesive polymers, 
chitosan is positively-charged through its free 
amino groups in the deacetylated 
glucosamine residues. Its polycationic nature 
is unusual among biopolymers in general. It 
has been shown to interact with mucin and 
liposomes coated with it have also been 
shown in vivo to have prolonged residence 
time in the gastrointestinal (GI) tract of rats 
relative to uncoated liposomes [19]. It is 
capable of developing additional molecular 
attractive forces by electrostatic interactions 
with negatively charged mucosal surfaces or 
negatively-charged sialic acid groups of the 
mucus network [17].  
 
The higher mucoadhesive potential observed 
with formulations containing only HPMC is 
probably due to the controlled rate of 
hydration of HPMC as a non-ionic polymer. 
This might have prevented the tablet from 
quick over-hydration and formation of slippery 
and weak mucilage that are easily removable 
from the mucosal surface. On the other hand, 
chitosan might have formed weaker, more 
easily fractured gels due to its comparatively 
low molecular weight in addition to very low 
rate of swelling, resulting in low 




The results obtained demonstrate that 
chlorhexidine tablets for mucoadhesive 
delivery are feasible. Optimum drug release 
and bioadhesive properties can be achieved 
when HPMC only was used as the 
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